Norac Pharma is a preferred California-based API contract research and manufacturing organization offering close partnership in bringing drugs to market through excellence in process development, analytical services and cGMP manufacture of Active Pharmaceutical Ingredients (API's) & intermediates. With over 40 years of API experience, including expertise in Controlled Substances and Potent Compounds, Norac Pharma delivers timely, efficient, and regulatory-compliant service in support of your API development needs. Our excellent track record in successful project delivery along with our extensive experience justifies your confidence in our ability to deliver, irrespective of target chemistry complexity.
| Website | http://www.noracpharma.com |
| Revenue | $21.5 million |
| Funding | $2 million |
| Employees | View employees |
| Address | 405 S Motor Ave, Azusa, California 91702, US |
| Fax | (626) 334-3512 |
| Industry | Drug Stores & Pharmacies, Retail |
| Competitors | Sorrento Therapeutics, Inc., Amgen, Puma Biotechnology, Inc., Genentech, Teva Pharmaceuticals, Bristol Myers Squibb, Gilead Sciences, Vertex Pharmaceuticals, Lilly India, Receptos, a wholly-owned subsidiary of Celgene +48 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Norac , Inc. employee's phone or email?
The Norac , Inc. annual revenue was $21.5 million in 2026.
Norac , Inc. is based in Azusa, California.
The NAICS codes for Norac , Inc. are [32541, 325, 3254, 32].
The SIC codes for Norac , Inc. are [283, 28].